Displaying items by tag: Division of Cardiovascular Disease

University of Alabama at Birmingham researchers have identified a therapeutic target to prevent or delay heart failure from pressure overload of the heart, and a potential biomarker for the same.
A new study published in JAMA Cardiology by UAB researchers shows that a key protein released from the heart is almost 35-percent lower in African-Americans than in Caucasians, and predicts the risk of death, particularly cardiovascular mortality similarly in both races.
UAB Medicine has a long history of caring for patients with adult congenital heart disease, and the Alabama Adult Congenital Heart Program is the only one in Alabama and one of a handful in the country that provide continuing care for patients as they move into adulthood.
A program that supports historically disadvantaged health professionals chooses two researchers in the UAB Department of Medicine as finalists.
A fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response.
Page 1 of 7